AC Immune and Takeda ink US$2.1bn biobucks deal
AC Immune and Takeda have inked an exclusive option license agreement for ACI-24.060, a first-in-class active immunotherapy designed to delay or slow Alzheimer’s disease progression. <ul><li></li></ul>
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1163 entries already.
Entries by Thomas Gabrielczyk
Memo Therapeutics AG increases Series C financing to CHF45m
/in News/by Thomas GabrielczykSwiss antibody specialist Memo Therapeutics AG has added CHF20m to its Series C financing, bringing the total amount raised in the funding round to CHF 45 million. <br /><br />
Full house at European Cluster Conference
/in News/by Thomas GabrielczykMore than 900 experts from clusters and the EU Commission discussed at the sold-out 9<sup>th</sup> European Cluster Conference what cluster policy is needed to make Europe a world leader in […]
Danish 21st.BIO A/S opens multipurpose production plant
/in News/by Thomas GabrielczykDanish CDMO 21st.BIO A/S has unveiled a new pilot plant facility to accelerate scaling of biotech processes ranging from food and beverages, agriculture, biomaterials, and biopharma. <br /> <br /><br […]
Protein flags Car-T cells for digestion by NK cells
/in News/by Thomas GabrielczykFlagging of CAR-T cells with the B7H6 protein weakened the response to human leukaemia in models as it marks them for NK cell attack, German researchers report.
Biotalys starts field testing for biofungicide
/in News/by Thomas GabrielczykBelgian AgTech specialist Biotalys BV an Agricultural Technology (AgTech) company has initiated field trials for BioFun-6, the company’s second llama-antibody-mimicking biofungicide program.
Three companies launch gene therapy alliance for eye diseases
/in News/by Thomas GabrielczykAI specialist WhiteLab Genomics, the Vision Institute, and IT expert ADLIN Science, have entered into a strategic partnership aimed at developing new AAV vectors targetting retinal dystrophies.
Obesity: reseachers switch on brown fat cells
/in News/by Thomas GabrielczykA German-Danish team has discovered that a truncated version of the enzyme adenlyate cyclase 3 can be targeted to transform fat-storing white adipocytes into fat-burning brown adipocytes.
Klineo raises €2m to speed up access to cancer trials
/in News/by Thomas GabrielczykParis-based Klineo SAS has raised €2M to speed up access to clinical trials for oncology patients using an AI platform.<br />`<br /><br />
Locate Bio Ltd raises £9.2m venture capital
/in News/by Thomas GabrielczykUniversity Nottingham spin out Locate Bio Ltd has added £9.2m venture financing led by Mercia Ventures and Business Growth Fund to its £16.2m raised before.